ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,048.42
-0.46%
Dow Jones
38,085.80
-0.98%
US Dollar vs MXN
17.19873
0.67%
Brent Oil
88.055
0.96%
Bitcoin
64,937.83
1.02%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NYSE
  6. Bristol Myers Squibb Co (BMY)

  7. Bristol Myers Squibb Co (BMY) Noticias

BMY Bristol Myers Squibb Co

44.88
-3.98 (-8.15%)
Fuera de horario
Última actualización: 15:46:07
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Bristol Myers Squibb Co BMY NYSE Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-3.98 -8.15% 44.88 15:46:07
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
47.195 44.37 47.33 44.70 48.86
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
25/4/202406:53IHMARKETNEWSU.S. Futures Drop in Pre-Market Trading as Tech Stocks..
25/4/202405:59BWBristol Myers Squibb Reports First Quarter Financial Results..
23/4/202406:25IHMARKETNEWSApple Loses Market Share in China, GM Surges in Pre-Market..
22/4/202405:59BWBristol Myers Squibb and Cellares Announce a $380M Worldwide..
08/4/202410:30BWKRAZATI (adagrasib) in Combination with Cetuximab..
06/4/202412:15BW Bristol Myers Squibb Presents New Pooled Interim Long-Term..
05/4/202408:05BWU.S. FDA Approves Bristol Myers Squibb and 2seventy bio’s..
02/4/202419:08BWEuropean Commission Expands Approval of Bristol Myers..
02/4/202405:59BWBristol Myers Squibb Releases 2023 Environmental, Social and..
28/3/202415:05BWBristol Myers Squibb Announces Pivotal KRYSTAL-12..
28/3/202415:01BWBristol Myers Squibb Provides Update on the First Phase 3..
28/3/202406:30GLOBEPerspective Therapeutics Provides Recent Business Highlights..
26/3/202413:25BWA Bristol Myers Squibb Expande as Iniciativas de Doações..
26/3/202405:59BWBristol Myers Squibb Expands Health Equity Grant Initiatives..
25/3/202407:00BWBristol Myers Squibb to Present Data at the American College..
20/3/202415:45BWBristol Myers Squibb’s Abecma (idecabtagene vicleucel)..
20/3/202405:59BWBristol Myers Squibb Announces CheckMate -9DW Trial..
19/3/202405:59BWBristol Myers Squibb and Ted Danson Empower Those with..
18/3/202407:44BWBristol Myers Squibb Completes Acquisition of Karuna..
15/3/202417:27BWFDA Advisory Committee Votes in Favor of Bristol Myers..
14/3/202420:35BWU.S. FDA Approves Bristol Myers Squibb’s Breyanzi® as the..
11/3/202415:16BWBristol Myers Squibb to Report Results for First Quarter..
07/3/202413:23BWU.S. Food and Drug Administration Approves Opdivo®..
06/3/202415:17BWBristol Myers Squibb to Participate in Upcoming Investor..
04/3/202416:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202416:52EDGAR2Form 3 - Initial statement of beneficial ownership of..
01/3/202415:16BWBristol Myers Squibb Announces Dividend
29/2/202405:59BWBristol Myers Squibb Announces New Data from the Long-Term..
26/2/202415:16BWBristol Myers Squibb to Participate in the TD Cowen 44th..
26/2/202407:35BWBristol Myers Squibb Completes Acquisition of RayzeBio,..
23/2/202417:03EDGAR2Form 3 - Initial statement of beneficial ownership of..
23/2/202406:34EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
23/2/202405:59BWBristol Myers Squibb Announces Expiration of RayzeBio Tender..
22/2/202415:15EDGAR2Form 8-K - Current report
20/2/202405:59BWU.S. Food and Drug Administration (FDA) Accepts Supplemental..
14/2/202418:57BWBristol Myers Squibb Prices $13 Billion of Senior Unsecured..
14/2/202415:16BWBristol Myers Squibb Recommends Stockholders Reject..
14/2/202405:59BWU.S. Food and Drug Administration Accepts for Priority..
12/2/202405:59BWBristol Myers Squibb and RayzeBio Announce Expiration of HSR..
07/2/202405:59BWBristol Myers Squibb Announces Acceptance of U.S. and EU..
05/2/202408:00BWBristol Myers Squibb Named One of America’s Most JUST..
05/2/202405:59BWBristol Myers Squibb and 2seventy bio Share Update on U.S...
02/2/202405:59BWBristol Myers Squibb Reports Fourth Quarter and Full-Year..
30/1/202405:59BWRegulatory Applications Accepted in the U.S. and Japan for..
27/1/202409:00BWSubcutaneous Nivolumab (nivolumab and hyaluronidase) Shows..
26/1/202406:13BWBristol Myers Squibb Receives Positive CHMP Opinion for CAR..
25/1/202407:13EDGAR2Form SC TO-T - Tender offer statement by Third Party
23/1/202407:30BWBristol Myers Squibb Completes Acquisition of Mirati..
22/1/202416:05BWEight-Year Data for Opdivo (nivolumab) Plus Yervoy..
22/1/202416:00BWOpdivo® (nivolumab) in Combination with CABOMETYX®..

Su Consulta Reciente

NYSE
BMY
Bristol Myers Squibb
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados